Nanowear Inc.
The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.
Covid19
Observational Study - no intervention
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 100 participants |
| Official Title : | The Nanowear Wearable Covid-19 Observational and Analysis Trend |
| Actual Study Start Date : | 2020-09-15 |
| Estimated Primary Completion Date : | 2023-12-31 |
| Estimated Study Completion Date : | 2023-12-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
NOT YET RECRUITING
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
RECRUITING
Maimonides Medical Center
Brooklyn, New York, United States, 11219